Liminatus Pharma, Inc. (LIMN)
0.3594
-0.13
(-25.91%)
USD |
NASDAQ |
Feb 13, 15:41
Liminatus Pharma Free Cash Flow : -10.38M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| CDT Equity, Inc. | -15.13M |
| LENZ Therapeutics, Inc. | -46.16M |
| Oruka Therapeutics, Inc. | -84.60M |
| Maze Therapeutics, Inc. | -108.03M |
| MapLight Therapeutics, Inc. | -109.22M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.6006M |
| Cash from Investing (Quarterly) | -0.0131M |
| Free Cash Flow Per Share (Quarterly) | -0.0227 |
| Free Cash Flow to Equity (Quarterly) | -0.6137M |
| Free Cash Flow to Firm (Quarterly) | -0.5946M |
| Free Cash Flow Yield | -138.5% |